Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
TAL Education Group
TAL
|
$885M |
| 2 |
Trip.com Group
TCOM
|
$259M |
| 3 |
Netflix
NFLX
|
$247M |
| 4 |
LendingTree
TREE
|
$186M |
| 5 |
NetEase
NTES
|
$116M |
Top Sells
| 1 |
Amazon
AMZN
|
$618M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$482M |
| 3 |
Royal Caribbean
RCL
|
$331M |
| 4 |
Baidu
BIDU
|
$298M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$294M |
Sector Composition
| 1 | Consumer Discretionary | 35.57% |
| 2 | Communication Services | 17.24% |
| 3 | Healthcare | 14.9% |
| 4 | Technology | 9.45% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Pacira BioSciences
PCRX
$1.19B
| $15.9M | 0.02% |
510,097
+139,935
| +38% | +$4.36M |
|
152
STAAR Surgical
STAA
$1.38B
| $15.9M | 0.02% |
1,071,975
+279,568
| +35% | +$4.14M |
|
153
Exelon
EXC
$43.9B
| $15.8M | 0.02% |
566,611
| – | – |
|
154
BlackLine
BL
$3.32B
| $15.5M | 0.02% |
+395,391
| New | +$15.5M |
|
|
KDNY
155
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $15.4M | 0.02% |
331,347
+122,824
| +59% | +$5.71M |
|
156
Eversource Energy
ES
$23.6B
| $15.2M | 0.02% |
257,553
+3,320
| +1% | +$196K |
|
157
Ameren
AEE
$27.2B
| $14.8M | 0.02% |
262,190
| – | – |
|
|
ONC
158
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $14.7M | 0.02% |
87,417
+166
| +0.2% | +$27.9K |
|
159
Exact Sciences
EXAS
$10.2B
| $14.6M | 0.02% |
362,293
+76,342
| +27% | +$3.08M |
|
160
Consolidated Edison
ED
$35.4B
| $14.5M | 0.02% |
185,972
| – | – |
|
|
PHD
161
Pioneer Floating Rate Fund
PHD
$123M
| $14.4M | 0.02% |
1,236,803
| – | – |
|
|
VAR
162
DELISTED
Varian Medical Systems, Inc.
VAR
| $14.4M | 0.02% |
117,375
| – | – |
|
163
RPM International
RPM
$16.2B
| $14.4M | 0.02% |
+301,184
| New | +$14.4M |
|
164
Stratasys
SSYS
$871M
| $13.4M | 0.02% |
666,051
+205,514
| +45% | +$4.15M |
|
165
Ambarella
AMBA
$3.54B
| $13M | 0.02% |
265,085
+68,548
| +35% | +$3.36M |
|
|
EVF
166
Eaton Vance Senior Income Trust
EVF
$101M
| $12.8M | 0.02% |
1,885,000
| – | – |
|
167
WEC Energy
WEC
$34.7B
| $12.8M | 0.02% |
204,107
| – | – |
|
168
Edison International
EIX
$21B
| $12.6M | 0.01% |
197,370
+910
| +0.5% | +$57.9K |
|
|
NSL
169
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $12.5M | 0.01% |
1,915,000
| – | – |
|
|
NCNA
170
NuCana
NCNA
$5.48M
| $12.1M | 0.01% |
128
+18
| +16% | +$1.71M |
|
171
CEVA Inc
CEVA
$543M
| $11.6M | 0.01% |
321,250
+105,861
| +49% | +$3.83M |
|
172
Weibo
WB
$2.87B
| $11.6M | 0.01% |
96,970
-1,163
| -1% | -$139K |
|
173
Lindblad Expeditions
LIND
$803M
| $11M | 0.01% |
1,072,701
| – | – |
|
174
PG&E
PCG
$33.2B
| $10.8M | 0.01% |
244,809
+2,910
| +1% | +$128K |
|
|
AFT
175
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $10.4M | 0.01% |
617,746
| – | – |
|